The estimated Net Worth of Patricia Carr is at least $3.1 Milión dollars as of 7 June 2024. Ms. Carr owns over 163 units of Jazz Pharmaceuticals plc stock worth over $693,437 and over the last 5 years she sold JAZZ stock worth over $2,404,140. In addition, she makes $0 as Vice President a Finance and Principal Accounting Officer at Jazz Pharmaceuticals plc.
Patricia has made over 22 trades of the Jazz Pharmaceuticals plc stock since 2019, according to the Form 4 filled with the SEC. Most recently she sold 163 units of JAZZ stock worth $17,739 on 7 June 2024.
The largest trade she's ever made was selling 3,704 units of Jazz Pharmaceuticals plc stock on 6 March 2024 worth over $438,442. On average, Patricia trades about 621 units every 59 days since 2019. As of 7 June 2024 she still owns at least 6,596 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Ms. Carr stock trades at the bottom of the page.
Patricia Carr serves as Vice President, Finance and Principal Accounting Officer of the Company. Prior to that, from September 2011 to July 2012, she served as Vice President, Finance of Alkermes plc, a global biopharmaceutical company. From June 2002 to September 2011, she served in a number of roles in Elan Corporation, a neuroscience-based biotechnology company, most recently as Vice President, Finance.
Patricia Carr is 49, she's been the Vice President a Finance and Principal Accounting Officer of Jazz Pharmaceuticals plc since 2019. There are 24 older and 3 younger executives at Jazz Pharmaceuticals plc. The oldest executive at Jazz Pharmaceuticals plc is Catherine Sohn, 67, who is the Independent Director.
Patricia's mailing address filed with the SEC is 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, L2, .
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright a Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: